Especifique uma ação ou criptomoeda na barra de pesquisa para obter um resumo
Jenscare Scientific Co Ltd
9877Jenscare Scientific Co., Ltd., a medical device company, engages in the research and development of interventional products for the treatment of structural heart diseases in the People's Republic of China. It offers LuX-Valve and LuX-Valve Plus, a transcatheter tricuspid valve replacement (TTVR) product for the treatment of severe tricuspid regurgitation and high surgical risk; and Ken-Valve, a transcatheter aortic valve replacement product candidate for the treatment of severe aortic regurgitation or combined with aortic stenosis. The company also develops JensClip, a clip-based transcatheter mitral valve (TMVR) repair system, and JensRelive, a TMVR transfemoral system to treat patients with severe mitral regurgitation; MicroFlux, a transcatheter device to treat heart failure with pressured ejection fraction; and SimuLock, a bionics left atrial appendage occluder system for cardiogenic stroke prevention. In addition, it is involved in consulting and investment activities. The company was incorporated in 2011 and is headquartered in Ningbo, the People's Republic of China. Address: Block 5, B Area, Ningbo, China
Analytics
Preço Alvo de Wall Street
342.61 HKDRácio P/E
–Rendimento de dividendos
–Ano atual
Ano passado
Trimestre Atual
Ultimo quarto
Ano atual
Ano passado
Trimestre Atual
Ultimo quarto
Figuras chave 9877
Análise de Dividendos 9877
Crescimento de dividendos em 5 anos
–Crescimento contínuo
–Taxa de pagamento em média de 5 anos
–Histórico de Dividendos 9877
Avaliação de ações 9877
Relatório 9877
Acompanhe as principais métricas de cada ação em um só lugar, sem complicações
Inscreva-se no premiumResultados | 2019 | Dinâmica |